Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burns patients

Indian Journal of Medical Research

Volumn 122, Issue 4, 2005, Pages 324-329

  Shahid, M ^a   Malik, Abida ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Aminoglycoside; Aminoglycoside resistance; Modifying enzymes; Pseudomonas aeruginosa

Indexed keywords

ACYLTRANSFERASE; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL ENZYME; CARBENICILLIN; CEFTAZIDIME; CIPROFLOXACIN; FORTIMICIN; GENTAMICIN; KANAMYCIN; NEOMYCIN; NETILMICIN; PAROMOMYCIN; PHOSPHOTRANSFERASE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BURN PATIENT; ENZYME MODIFICATION; HOSPITAL PATIENT; HUMAN; INDIA; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PLASMID; PSEUDOMONAS AERUGINOSA;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BURNS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PSEUDOMONAS AERUGINOSA; R FACTORS;

EID: 30744466896     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rice LB, Bonomo RA. Genetic and biochemical mechanisms of bacterial resistance to antimicrobial agents. In: Lorian V. editor. Antibiotics in laboratory medicine, 4th ed. Baltimore, MD: Williams & Wilkins 1996 p. 453-501.
2. Barnhart C, Campbell R, LaRosa LA, Marr AM, Morgan A, Van Berkom D. Aminoglycosides: Mechanism of Resistance http://www.uphs.upenn.edu/bugdrug/antibiotic_manual/ aminoglycosideresistance.nhs,accessed on 22 March 2003.
3. Shahid M, Malik A. MDR Pseudomonas aeruginosa strains in burn wounds: Plasmid mediated resistance. Bionotes; 2003: 5: 6-7.
4. Kucers A, Crowe S, Grayson ML, Hoy J, editors. The use of antibiotics: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs, 5th Ed. Oxford: Butterworth Heinemann. 1997 p. 452-7.
5. Miller GH, Sabatelli FJ, Hare RS, Glupczynski Y, Mackey P, Shlaes D, et al. The most frequent aminoglycoside resistance mechanisms - changes with time and geographic area a reflection of aminoglycoside usage patterns. Aminoglycoside Resistance Study Groups. Clin Infect Dis 1997; 24: (Suppl I): S46-62.
6. Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother 2001; 48: (Suppl I): 87-102.
7. Shahid M, Malik A, Sheeba. Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC β-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India. FEMS Microbiol Lett 2003; 228: 181-6.
8. Bauer W, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45: 493-6.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 8th Information supplement. NCCLS document M 100-S8: National Committee for Clinical Laboratory Standards 1998; Villanova PA.
10. Mingeot - Leclercq MP, Glupczynski Y, Tulkens PM. Aminoglycosides: activity and resistance. Antimicrob Agents Chemother 1999; 43: 727-37.
11. Biswas SK, Kelkar RS. In vitro comparative evaluation of aminoglycosides at a cancer centre. Indian J Cancer 2002; 39: 135-8.
12. van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother 2003; 51: 347-52.
13. Garbino J, Loffler J, Rohner P, Lew D, Auckenthaler R. Antibiotic consumption and development of resistance in intensive care units. Clin Microbiol Infect 2000; 6: (Suppl I) 46.
14. Singh NP, Goyal R, Manchanda V, Das S, Kaur I, Talwar V. Changing trends in bacteriology of burns in the burns unit, Delhi, India. Burns 2003; 29: 129-32.
15. Shaw KJ, Rather PN, Hare RS, Miller GH. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside - modifying enzymes. Microbiol Rev 1993; 57: 138-63.
16. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002; 34: 634-40.
17. Kettner M, Milosovic P, Hletkova M, Kallova J. Incidence and mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa serotype 011 isolates. Infection 1995; 23: 380-3.
18. Courvalin P. Interpretative reading of antimicrobial susceptibility tests. ASM News 1992; 58: 368-75.
19. Vedel G, Peyret M, Gayral JP, Millot P. Evaluation of an expert system linked to a rapid antibiotic susceptibility testing system for the detection of β-lactam resistance phenotypes. Res Microbiol 1996; 147: 297-309.